Ferritin Is A Potential Tumor Marker For Colorectal Cancer And Modulates Histone Methylation In Colorectal Cancer Cells

Lin-Lin Cao,Hang-Qi Liu,Zhi-Hong Yue,Lin Pei,Hui Wang,Mei Jia

2019-01-01

Abstract:Purpose: Colorectal cancer (CRC) is a severe public health problem worldwide. Due to the insufficient sensitivity and/or specificity of traditional tumor markers, it is essential to identify new tumor markers to better diagnose and cure CRC. In this study, we aimed to determine whether serum ferritin could be a potential biomarker for CRC. Material and Methods: A total of 62 CRC patients were included in this study. The serum concentrations of ferritin, CEA, CA19-9 and CA125 were detected by the Cobas e601 electrochemiluminescence immunoassay system. The role of FTH1, the heavy subunit of ferritin, in CRC cells was explored using molecular biology methods. Results: We found that the serum ferritin level in CRC patients was higher than that in healthy controls, and the concentrations of serum ferritin were associated with clinicopathological features, such as the tumor stage and lymph node status of CRC patients. Interestingly, a correlation existed between ferritin and CEA, as well as CA19-9, in CRC patients, suggesting the potential of serum ferritin as a novel CRC tumor marker. Additionally, the expression of SUV39H1, a critical regulator of CRC progression and development, was modulated by the ferritin heavy subunit (FTH1), and FTH1 knockdown downregulated the expression of histone methyltransferase SUV39H1. Correspondingly, H3K9me2/3 (H3K9me2 and H3K9me3), the catalytic product of SUV39H1, was also reduced following FTH1 knockdown. Conclusions: This study revealed a novel role for ferritin in CRC diagnosis and is the first to demonstrate that SUV39H1 and H3K9me2/3 were modulated by FTH1 CRC cells.